National and international differences in the prices of branded and unbranded medicines

Journal of Generic Medicines

Volumn 1, Issue 2, 2004, Pages 120-127

  Tafuri, Giovanni ^a   Creese, Andrew ^a   Reggi, Valerio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACICLOVIR; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ATENOLOL; BECLOMETASONE; CAPTOPRIL; CARBAMAZEPINE; CIPROFLOXACIN; COTRIMOXAZOLE; DIAZEPAM; DICLOFENAC; FLUOXETINE; GENERIC DRUG; GLIBENCLAMIDE; IBUPROFEN; METFORMIN; NAPROXEN; NIFEDIPINE; PARACETAMOL; PHENYTOIN; RANITIDINE; SALBUTAMOL;

ARTICLE; CONSUMER; CONTROLLED STUDY; DRUG COST; DRUG MARKETING; EASTERN EUROPE; GERMANY; GOVERNMENT REGULATION; HEALTH CARE POLICY; MATHEMATICAL COMPUTING; PHARMACEUTICAL CARE; REIMBURSEMENT; SENSITIVITY ANALYSIS; STANDARDIZATION; TAX; WESTERN EUROPE;

EID: 33846886960     PISSN: 17411343     EISSN: 17417090     Source Type: Journal    
DOI: 10.1057/palgrave.jgm.4940003     Document Type: Article

References (18)

1. Jommi, C. (2000) 'Pharmaceutical Policy and Organisation of the Regulatory Authorities in the Main EU Countries', 1st edn, Egea, Milan, pp. 15-17.
2. World Health Organization (2001) 'Globalisation, TRIPS and Access to Pharmaceuticals', in 'WHO Policy Perspectives on Medicines', WHO, Geneva, Switzerland.
3. Smith, S. R. (2002) 'Multinational economic evaluations of pharmaceuticals', Lancet, Vol. 360, p. 816.
4. Jacobzone, S. (2000) 'Pharmaceutical policies in OECD countries: Reconciling social and industrial goals', Labour Market and Social Policy, Occasional Employment, Labour and Social Affairs, Organization for Economic Co-operation and Development, p. 9.
5. World Health Organization and Health Action International (2003) 'Medicine prices: A new approach to measurement', Working draft for field testing and revision, WHO/HAI, Geneva/Amsterdam.
6. IMS Health (2000) Customised studies for the World Health Organization.
7. Available from: www.ministerosalute.it/medicinali/bancadati/sceltapa.asp and www.doh.gov.uk/, accessed September 2002.
8. Thesaurus Vidal-Semp® CD-ROM. Copyright Vidal, 2002.
9. eBNF 43 (March 2002), MeReC (Jan 1994-Mar 2002) CD-ROM. BNF 2002 British Medical Association and Royal Pharmaceutical Society of Great Britain; MeReC 2002 National Prescribing Centre; Browser 2002 Quartet Software Ltd.
10. Data provided by: Gisbert W. Selke, Research Institute of Allgemeine Ortskrankenkasse (AOK), Bonn, Germany (http://www.wido.de). Data received 2nd December, 2002.
11. Data provided by Prof. Dr. Vladimir S. Shoukhov, MD, DSc (Med), WHO Special Project on Pharmaceuticals in NIS, Russia. Data received 2nd December, 2002.
12. Data provided by Makhmudova Mavluda, Abdulazizov Salim, Isupov Salomuddin, National Pharmaceutical Taskforce of Tajikistan. Data received 22nd January, 2003.
13. Data provided by Saliya Karymbaeva, Head of Drug information Centre, Department of Drug Provision and Medical Equipment, Ministry of Health, Bishkek, Kyrgyzstan. Data received 22nd November, 2002.
14. Data provided by Eva Orlewska, MD, PhD and Malgorzata Cel MSc, National Institute of Public Health, Warsaw, Poland. Data received on November 19th 2002.
15. Data provided by Assistant Professor Karel Nemecek, MD, General Insurance Company of the Czech Republic, Prague, Czech Republic. Data received 3rd December, 2002.
16. WHO Collaborating Centre for Drug Statistics Methodology (2002) 'ATC Index with DDDs', WHO, Oslo, Norway.
17. WHO Collaborating Centre for Drug Statistics Methodology (2000) 'Guidelines for ATC Classification and DDD Assignment', WHO, Oslo, Norway, p. 20.
18. The Henry J. Kaiser Family Foundation (2000) 'Prescription Drug Trends: A Chartbook', Menlo Park, CA, p. 37.